Literature DB >> 18052947

Migraine and the risk of stroke, TIA, or death in the UK (CME).

Claudia Becker1, Gunnar P Brobert, Per M Almqvist, Saga Johansson, Susan S Jick, Christoph R Meier.   

Abstract

BACKGROUND: Previous observational studies have reported a higher risk of stroke in migraine patients. Objective.- We aimed to estimate the risk of stroke, transient ischemic attack (TIA), or death in migraineurs in the UK.
METHOD: We conducted a population-based follow-up study within the General Practice Research Database from 1994 to 2001.
RESULTS: The relative risk (RR) of stroke in migraineurs compared with non-migraineurs was 2.2 (95% confidence interval [CI] 1.7-2.9). It was highest for patients with a migraine diagnosis recorded within 30 days prior to a stroke (odds ratio 11.1, 95% CI 5.69-21.5). The RR of TIA in migraineurs compared with non-migraineurs was 2.4 (95% CI 1.8-3.3), the mortality of migraineurs was slightly decreased.
CONCLUSION: In our study, the RR of developing a stroke or a TIA was doubled in migraineurs as compared with non-migraineurs, while that for death was close to unity.

Entities:  

Mesh:

Year:  2007        PMID: 18052947     DOI: 10.1111/j.1526-4610.2007.00937.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  10 in total

Review 1.  Migraine and mortality: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert E Shapiro; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-07-29       Impact factor: 6.292

2.  Migraine headache and ischemic stroke risk: an updated meta-analysis.

Authors:  June T Spector; Susan R Kahn; Miranda R Jones; Monisha Jayakumar; Deepan Dalal; Saman Nazarian
Journal:  Am J Med       Date:  2010-05-20       Impact factor: 4.965

Review 3.  Migraine with and without aura and risk for cardiovascular disease.

Authors:  Bert B Vargas; David W Dodick; Dean M Wingerchuk; Bart M Demaerschalk
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

4.  Microembolus detection by transcranial Doppler sonography: review of the literature.

Authors:  Vlasta Vuković-Cvetković
Journal:  Stroke Res Treat       Date:  2011-11-30

5.  Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects.

Authors:  Ahmed N Mahmoud; Amgad Mentias; Akram Y Elgendy; Abdul Qazi; Amr F Barakat; Marwan Saad; Ala Mohsen; Ahmed Abuzaid; Hend Mansoor; Mohammad K Mojadidi; Islam Y Elgendy
Journal:  BMJ Open       Date:  2018-03-27       Impact factor: 2.692

6.  Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies.

Authors:  Timothy R Smith; Egilius L H Spierings; Roger Cady; Joe Hirman; Anders Ettrup; Vivienne Shen
Journal:  J Headache Pain       Date:  2021-11-25       Impact factor: 7.277

7.  Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database.

Authors:  Martin C Gulliford; Judith Charlton; Mark Ashworth; Anthony G Rudd; Andre Michael Toschke
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

8.  Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study.

Authors:  Chun-Hung Tseng; Jiunn-Horng Chen; Yu-Chiao Wang; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 9.  Migraine and Stroke: What's the Link? What to Do?

Authors:  Anna Gryglas; Robert Smigiel
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

10.  Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.

Authors:  Mark E Bangs; David Kudrow; Shufang Wang; Tina M Oakes; Gisela M Terwindt; Delphine Magis; Laura Yunes-Medina; Virginia L Stauffer
Journal:  BMC Neurol       Date:  2020-01-17       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.